Susheel Dua, MD
Pain Medicine · Atlanta, GANPI 1467598904
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $23,495 of the $36,320 with a category attached, or 64.7%. Avanos Medical accounts for 80.5% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $16,909 and has fallen 95.4% since, to $785 in 2025. Among pain medicine clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 244 payments — averaging $148.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanos Medical$29K
- Abbott$2K
- Boston Scientific$1K
- Collegium Pharmaceutical, Inc.$973
- Medtronic$490
- AbbVie$371
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$23,49565%
- Travel & lodging$7,04619%
- Food & beverage$5,78016%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanos Medical | 22 | $29,246 |
| Abbott | 19 | $2,129 |
| Boston Scientific | 36 | $1,384 |
| Collegium Pharmaceutical, Inc. | 72 | $973 |
| Medtronic(2 entities) | 12 | $490 |
| AbbVie(2 entities) | 18 | $371 |
| Nevro Corp. | 7 | $311 |
| SPR Therapeutics, Inc | 9 | $248 |
| Averitas Pharma Inc. | 3 | $203 |
| Forte Bio-pharma LLC | 2 | $162 |
| MDD US Operations, LLC | 7 | $130 |
| Pfizer | 6 | $84 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $84 |
| Lilly USA, LLC | 3 | $62 |
| Sentynl Therapeutics, Inc. | 4 | $54 |
| Tersera Therapeutics LLC | 2 | $52 |
| Merz Pharmaceuticals, LLC | 2 | $49 |
| Novartis | 1 | $49 |
| Daiichi Sankyo Inc. | 3 | $44 |
| Merck | 2 | $35 |
| Vertex | 1 | $33 |
| Virtus Pharmaceuticals LLC | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| GRT US Holding, Inc. | 1 | $23 |
| Flower Orthopedics Coporation | 1 | $20 |
| Biodelivery Sciences International, Inc. | 1 | $18 |
| Redhill Biopharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COOLIEF$26,683
- PROCLAIM$1,801
- COOLIEF* COOLED RADIOFREQUENCY$1,443
- GENERATOR$694
- WaveWriter Alpha Prime 16$286
- GENERAL PAIN MANAGEMENT$149
- INTELLIS ADAPTIVESTIM$144
- Omnia$140
- SUPERION$135
- SPRINT PNS System$128
- Qutenza$117
- Intracept$116
How this compares
$36,320 in reported general payments places this provider in the 95th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 125 | $92,553 |
| Xtampza ErOxycodone Myristate | 107 | $68,691 |
| Buprenorphine | 207 | $55,225 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 600 | $39,942 |
| OxycontinOxycodone Hcl | 54 | $33,465 |
| MovantikNaloxegol Oxalate | 48 | $20,028 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 668 | $13,334 |
| Fentanyl | 115 | $12,260 |
| ButransBuprenorphine | 18 | $9,059 |
| Gabapentin | 528 | $8,067 |
| Pregabalin | 342 | $7,135 |
| Oxycodone Hcl | 361 | $5,632 |
| Morphine Sulfate ErMorphine Sulfate | 219 | $5,315 |
| Lidocaine | 39 | $3,846 |
| Celecoxib | 135 | $2,494 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $973 | $161,244232 claims |
| Redhill Biopharma Inc.Movantik | $13 | $20,02848 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 203 pain medicine providers in Georgia.
Other pain medicine in Atlanta
- Muhammad QadriAtlanta$14K
- Evesha KenlynAtlanta$9K
- Thomas XuAtlanta$7K
- Ashley RogersAtlanta$5K
- Rutvij ShahColumbus$86K
- Siddardth UmapathyFort Eisenhower$41K
- Subodh AgrawalAthens$34K
- Jose MathewLawrenceville$27K
- Zhuo SunAugusta$26K
- Maged HamzaGainesville$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.